Bylgja Hilmarsdottir

Reykjavik, 101, Iceland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Targeted therapy in the treatment of lung cancer in Iceland 2010-2023.

Targeted therapy in the treatment of lung cancer in Iceland 2010-2023.

Journal: Acta oncologica (Stockholm, Sweden)
Published: December 01, 2025

High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer.

High Atlastin 2-2 (ATL2-2) Expression Associates with Worse Prognosis in Estrogen-Receptor-Positive Breast Cancer.

Journal: Genes
Published: June 20, 2023

Application of 3D Culture Assays to Study Breast Morphogenesis, Epithelial Plasticity, and Cellular Interactions in an Epithelial Progenitor Cell Line.

Application of 3D Culture Assays to Study Breast Morphogenesis, Epithelial Plasticity, and Cellular Interactions in an Epithelial Progenitor Cell Line.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 04, 2022

Advances in lung cancer diagnosis and treatment - a review

Advances in lung cancer diagnosis and treatment - a review

Journal: Laeknabladid
Published: December 20, 2021

Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.

Hsa-miR-21-3p associates with breast cancer patient survival and targets genes in tumor suppressive pathways.

Journal: PloS one
Published: July 23, 2021

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer.

Argininosuccinate lyase is a metabolic vulnerability in breast development and cancer.

Journal: NPJ systems biology and applications
Published: January 29, 2021

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Journal: Molecular oncology
Published: August 16, 2020

Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells.

Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells.

Journal: Frontiers in cell and developmental biology
Published: December 12, 2019

The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability.

The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability.

Journal: Genes
Published: August 16, 2019

ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion.

ECM1 secreted by HER2-overexpressing breast cancer cells promotes formation of a vascular niche accelerating cancer cell migration and invasion.

Journal: Laboratory investigation; a journal of technical methods and pathology
Published: May 13, 2019

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.

Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer.

Journal: Breast cancer research : BCR
Published: January 04, 2019

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

Journal: Scientific reports
Published: December 19, 2018
Showing 1-12 of 22

Last Updated: 09/26/2026